Portfolio company
DBV Technologies
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
Digital Health
About
The company develops non-invasive epicutaneous immunotherapy patches to treat food allergies and immunological disorders in paediatric and adult patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.